The aging population of the United States creates pharmaceutical challenges for the practicing emergency physician. Polypharmacy, drug-drug and drug-disease interactions, and other pharmaceutical complications from the pathophysiologic changes associated with aging need to be recognized in order to optimize outcomes in the elderly. Effective strategies that improve patients outcomes include a better understanding of the physiologic and pharmacologic changes that occur with aging, integrated use of clinical emergency department pharmacists, and choosing nonpharmacologic treatment options when possible.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2afml5Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
This feed no longer exists. Cambridge Journals Online and Cambridge Books Online have been replaced by Cambridge University Press’s new acad...
-
Abstract In this work, novel thin-film composite forward osmosis (TFC-FO) hollow fiber membranes were fabricated by modifying polyamide ac...
-
Objectives: Opioids and benzodiazepines are commonly used to provide analgesia and sedation for critically ill children with cardiac disease...
-
Objective: Inotropic and vasopressor drugs are routinely used in critically ill patients to maintain adequate blood pressure and cardiac ou...
-
Academic Emergency Medicine, EarlyView. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2Lq7OXW
-
Abstract The dispersion properties of Love waves are utilized for the fabrication of sensor devices in the different material environments...
-
Plasminogen activator inhibitor-1 gene polymorphisms in systemic lupus erythematosus: is there a risk for lupus nephritis among Egyptians? A...
-
EMS providers should be on high alert for fraud and forgery in the patient care report from EMS via xlomafota13 on Inoreader https://ift.t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου